We use cookies on this website to enhance your browser experience. By continuing to use this site, you are providing us with your consent to our use of cookies on the site. To learn more about cookies and how we use them, please review our privacy policy.
Oversight Overhaul: Eliminating the Premarket Review of Medical Devices and Implementing a Provider-Centered Postmarket Surveillance Strategy, in Food & Drug Law Journal